A new study from researchers at the Alliance for Clinical Trials in Oncology (Alliance) shows that patients with stage III ...

Targeted therapies are a type of medicine used to treat cancer. They work differently than standard chemotherapy. Instead of killing all fast-growing cells or keeping them from dividing, targeted ...

While there are several treatment options for colon cancer, not all of them work for all cancer types. Deficient mismatch repair (dMMR) colon cancer is known to be less responsive to chemotherapy than ...

People battling advanced colon cancers might have a new treatment option that could extend their survival, a new trial finds. A combination of two experimental immunotherapy drugs plus standard ...

Please provide your email address to receive an email when new articles are posted on . Patients with stage III or high-risk stage II colon cancer in a structured exercise program had 28% lower risk ...

An interview with Dr. Nancy Baxter from the University of Melbourne in Melbourne, Australia, and Dr. Jeffrey Meyerhardt from Dana-Farber Cancer Institute in Boston, MA, co-chairs on “Adjuvant Therapy ...

GLP-1 receptor agonist therapy for type 2 diabetes or obesity is associated with a significantly lower risk of developing ...

Serial circulating tumor DNA analysis can demonstrate rapid clonal dynamics that evolve during response and resistance to both standard chemotherapy and targeted therapy of BRAF-mutant colon cancer ...

Better out than in, they say? At least that seems to be the general consensus amongst the who’s who of the wellness community—where colonics seem to be all the rage. If you’re not familiar with the ...

The identification of rare genomic alterations in patients with colorectal cancer gives oncologists the opportunity to treat patients who otherwise might not have many options. When Mia Balko, 48, ...